Rivamer 1.5 Mg Capsule (Rivastigmine)
$61.25 – $115.06Price range: $61.25 through $115.06
United States dollar ($) - USD
-
United States dollar ($) - USD
-
Euro (€) - EUR
-
Canadian dollar ($) - CAD
Available Options
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 30 Capsule/s | $61.25 | $2.04 / capsule | ||
| 60 Capsule/s | $90.18 | $1.50 / capsule | ||
| 90 Capsule/s | $115.06 | $1.28 / capsule |
Want to order in bulk / get a B2B price?
Send Inquiry
18
People watching this product now!
Estimated delivery: August 20, 2026 – August 25, 2026
Additional information
| Packaging | Qty |
|---|---|
| Delivery Time | 6 To 15 days |
Reviews (0)
Be the first to review “Rivamer 1.5 Mg Capsule (Rivastigmine)” Cancel reply
Related products
Admenta 5 Mg (Memantine)
Rated 0 out of 5
(0)
Starting at just $0.91 / tablet
Select options
This product has multiple variants. The options may be chosen on the product page
Cerecetam 400 Mg Tablet (Cerebrolysin)
Rated 0 out of 5
(0)
Starting at just $0.72 / tablet
Select options
This product has multiple variants. The options may be chosen on the product page
Donep 10 Mg (Donepezil)
Rated 0 out of 5
(0)
Starting at just $1.15 / tablet
Select options
This product has multiple variants. The options may be chosen on the product page
Donep M Forte Tablet (Donepezil)
Rated 0 out of 5
(0)
Starting at just $1.62 / tablet
Select options
This product has multiple variants. The options may be chosen on the product page
Exelon Patch 15 (Rivastigmine)
Rated 0 out of 5
(0)
Starting at just $101.43 / pack
Select options
This product has multiple variants. The options may be chosen on the product page
Nemdaa 5 Mg Tablet (Memantine)
Rated 0 out of 5
(0)
Starting at just $0.78 / tablet
Select options
This product has multiple variants. The options may be chosen on the product page
Rivamer 3 Mg (Rivastigmine)
Rated 0 out of 5
(0)
Starting at just $1.62 / capsule
Select options
This product has multiple variants. The options may be chosen on the product page

Reviews
There are no reviews yet.